Interventional Cardiology & Peripheral Vascular Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

Cardiovascular diseases, one of the primary cause of the global mortality was responsible for 17.7 million deaths worldwide, as reported by the World Health Organization (WHO). This global burden of death raised the importance of taking preventive health measures and focusing into development of improved treatment devices in order to achieve effective clinical outcomes. Interventional method deployment in cardiology and peripheral vascular disease treatment is mostly preferred to avoid complications and scar, reducing pain and faster recovery.

The research report titled ‘Interventional Cardiology and Peripheral Vascular Devices Market - Growth, Future Prospects, and Competitive Analysis, 2021 – 2029' is to provide industry experts and business executives with overall in-depth analysis to empower them for building business strategies and in the process of tactical decision making related to the prospects of interventional cardiology and peripheral vascular devices market. The report effectively conveys the comprehensive investigation of market dynamics containing significant market driving factors, limitations, opportunities and challenges. This report additionally gives key existing patterns and future extent of the interventional cardiology and peripheral vascular devices in conjunction with information for the base year 2016 and forecast from 2021-2029.

Interventional cardiology and peripheral vascular devices market is experiencing lucrative growth with a moderate CAGR owing to increase in prevalence of cardiovascular diseases. Surging inclination towards minimally invasive procedures will propel the growth of interventional cardiology and peripheral vascular devices market in the near future. Cardiovascular diseases are more prevalent in elderly population, thus rising geriatric population contributes major growth to the interventional cardiology and peripheral vascular devices market. An upsurge in high cholesterol, hypertension, and diabetes mellitus as a result of sedentary lifestyle is expected to drive the market growth. In the span of 2015-2016, American Heart Association funded more than US$ 163.0 million for 980 research projects into cardiovascular diseases; such increasing expenditure of government for betterment of health has driven substantial market growth. Escalating health awareness among public with various healthcare initiatives in developing nations contributes to the market growth. Evolving technological advancement for developing improved devices and favorable reimbursement policies are further projected for driving the growth of interventional cardiology and peripheral vascular devices market. Furthermore, the high cost of treatment procedures and options of traditional open surgical procedures might pose challenges to the smooth growth of the market.

Global interventional cardiology and peripheral vascular devices market has been classified into different types of products deployed for the purpose of cardiovascular diseases treatment such as angioplasty stents, balloon catheter, guidewires, vascular closure devices, peripheral embolic protection devices, atherectomy devices, endovascular stent grafts, vascular grafts, thrombectomy devices, inferior vena cava filter and other interventional devices. This report covers the cross-sectional data of each and every segment considering 2020 as base year and predicted the market trend up to 2029 along with CAGR of 2021-2029.

Based on the geographical regions, the global market of interventional cardiology and peripheral vascular devices has been classified into major regions and the sub-regions as below:

• North America
• The U.S.
• Canada
• Europe
• The U.K.
• Germany
• Rest of Europe
• Asia Pacific
• India
• Japan
• China
• Rest of Asia Pacific
• Latin America Middle East and Africa
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• GCC
• Rest of Middle East and Africa

This research report incorporates exhaustive profiling of couple of prevailing players of interventional cardiology and peripheral vascular devices market along with complete financial details and the key industry players are Cook Medical, Inc., Boston Scientific Corporation, Cardinal Health, Inc., St. Jude Medical, Abbott Laboratories, C. R. Bard, Inc., Medtronic plc., Edwards Lifesciences Corporation, Terumo Corporation, B. Braun Melsungen AG, Baxter International Inc., 3M Company, and other noteworthy players.

Based on the various types of products utilized in interventional cardiology and to treat peripheral vascular disease, the global interventional cardiology and peripheral vascular devices market is categorized as below:

• Angioplasty Stents
• Angioplasty Balloon Catheter
• Guidewires
• Vascular Closure Devices
• Peripheral Embolic Protection Devices
• Atherectomy Devices
• Endovascular Stent Grafts
• Vascular Grafts
• Thrombectomy Devices
• Inferior Vena Cava Filter
• Others (Hemodynamic Flow Alteration Devices, Plaque Modification Devices, Balloon Inflation Devices)

Coronary heart disease is the most common heart ailment affecting millions of people across the globe. Interventional cardiac procedures are witnessing increase in demand since angioplasty has revolutionized the treatment of coronary diseases by lowering post-surgery cardiac complications, reducing risk of nosocomial infections and faster recovery. Preference of angioplasty stents is on the rise due to rising prevalence of atherosclerosis where mesh like stent acts as a support to keep blocked vessel open. However, risk of restenosis would hamper the overall growth of stent and subsequently interventional cardiology and peripheral vascular devices market. Angioplasty balloon catheters are experiencing lucrative growth as it ensures safety and efficient results which is driving the market growth. Fuelled by technological advancements, vascular closure devices have successfully provided improved interventional procedures compared to manual closure technique, thereby boosting the industry growth. Thrombectomy devices, atherectomy devices, and embolic protection devices offer effective clinical outcomes and lower the chances of restenosis. The paradigm shift towards interventional approaches in order to treat cardiovascular diseases has propelled the global market. Furthermore, the traditional and conventional approach to treat cardiovascular disease and high cost of treatment might pose challenges on the growth of global interventional cardiology and peripheral vascular devices market.

Geographically, the global interventional cardiology and peripheral vascular devices market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global interventional cardiology and peripheral vascular devices market is anticipated to be dominated by North America followed by Europe. The Centers for Disease Control and Prevention (CDC) stated that every year 610,000 deaths occur due to cardiovascular diseases in the United States. Cardiovascular diseases are considered to be the leading cause of death in North America due to sedentary lifestyle and obesity. According to the British Heart Foundation, in the United Kingdom, 7 million people were suffering from cardiovascular disease in the year 2020. Such high prevalence of cardiovascular diseases drive the interventional cardiology and peripheral vascular devices market. However, the interventional cardiology and peripheral vascular devices market in North America is expected to face some challenges due to competitive pricing pressure and decrease in the insured inhabitants after the financial downturn of the nation.

The statistics published by American Heart Association revealed that in Asia-Pacific, 6.1% population had heart disease, 3.7% population was suffering from coronary heart disease and 21% had hypertension in the year 2020. The market of Asia Pacific is expected to experience sharp rise during the forecast period due to growing prevalence of cardiovascular diseases, predominantly in Japan. Japan contributes maximum share to the total sales of interventional cardiology and peripheral vascular devices across Asia Pacific due to highest geriatric population who are more susceptible to cardiac disease. The risk factors associated with cardiovascular disorders such as prevalence of high cholesterol, hypertension, diabetes mellitus are on rise, which play as major role in the market growth of interventional cardiology and peripheral vascular devices. As per the recorded data by the Institute for Health Metrics and Evaluation, 97% increase in cardiovascular death was observed between 1990 and 2013. However, emerging healthcare awareness, developing economies and healthcare infrastructure support the growth opportunity of interventional cardiology and peripheral vascular devices market in Asia Pacific region.

The global interventional cardiology and peripheral vascular devices market is presented as follows:

• North America (The United States & Canada)
• Europe (The United Kingdom, Germany, and rest of European countries)
• Asia Pacific (India, Japan, China and rest of Asia Pacific countries)
• Latin America (Mexico, Brazil, and rest of LATAM countries)
• Middle East and Africa (GCC, South Africa and rest of MEA countries)

This product will be delivered within 2 business days.